The results of this study essentially show that in rats, body weight regulation is not susceptible to neonatal programming following LPS-stimulation with neither body weight nor body composition found to be altered in the adult rats. Part of the aim of the study was also to monitor the changes in the levels of immune mediators induced by the inflammatory challenge. Previous reports have implicated long-term changes in the levels of pro-inflammatory cytokines including tumor necrosis factor(TNF)-and interleukin(IL)-1 the changes in the concentration of which was associated with alterations of various physiological parameters following LPS treatment of neonates (4, 10, 29) . It was however another mediator, leptin, that was investigated in the present study. This hormone is known primarily for its control of food intake but more importantly in the context of the present manuscript, in the development of the hypothalamic circuitry responsible for appetite regulation in young animals (8) . This makes it an obvious target for examination in studies assessing long-term changes in the mechanisms regulating appetite. Spencer et al., have also taken into consideration the recently described role of this adipose derived hormone in inflammation, thus making it a prime candidate for regulating and potential programming of body weight resulting from a neonatal inflammatory challenge. A great deal of the evidence linking leptin with LPS induced inflammation are the observations that it is upregulated in the circulation of LPS treated animals (3, 12, 14, 24) . This in addition to earlier evidence from our own laboratory (16) showing that as well as suppressing appetite, leptin can also induce fever in rats, suggested strongly that this hormone could in fact be acting as an immune mediator in the same mode as other pro-inflammatory cytokines. In the study of Spencer et al measurements of leptin levels of all the animals in the different treatment, age and -4 -gender groups showed no increase in the levels of this hormone after LPS injection. This the authors found surprising, given the reported changes in the literature but offer the explanation that this may have been due to procedural differences including doses of LPS (100µg/kg) used or the time (2.5h) the samples were collected. These parameters differ significantly from some of the studies reporting an LPS induced increase in the levels of circulating leptin and that may indeed explain the observations, or lack of them, in the Spencer study. As the authors point out however, the dose of LPS used in their study is one that they have used previously and repeatedly to induce long-term alterations in adult physiological, behavioral and endocrine responses (6, 7, 10, 11, 26-30). Thus one would have expected a difference in the levels of this hormone if indeed it was physiologically relevant to the long-term changes reported previously. The largely unchanged levels of circulating leptin (a significant reduction was observed in some of the female cohorts) might however reflect the negative outcome of the study in that no evidence of long term changes in body weight were observed. What is somewhat troubling about the lack of effect of LPS on leptin levels if one were to argue for the involvement of this hormone in mediating at least part of the inflammatory response induced, is the contradictory data in the literature. One of the first criteria that a circulating mediator has to fulfill to be designated a mediator of inflammation is that its circulating levels have to reflect at least we only observed a moderate increase 8h following a single injection of LPS at 100µg/kg which did not reflect the changes in body temperature observed. It is important to note here that most of the studies showing an effect of LPS on circulating plasma leptin levels were conducted in food restricted rodents (3, 12, 14, 24) . Given these observations and the fact that the antiserum studies clearly indicate that leptin is involved in mediating some aspects of LPS induced inflammation, we are currently pursuing the hypothesis that it may be acting at the level of adipose tissue by modulating the release of other proinflammatory, fat derived cytokines (32).
Other than mechanistic considerations it is clear that the complexity and variety of environmental factors involved can significantly influence the outcome of studies of this type. These pertain mostly to very basic issues such as gender, maternal care and housing environment. Maternal behavior for example has been shown to potentially ameliorate social-developmental effects of early illness (15) . Other factors such as neonatal handling developmental stages between the two species. Rat CNS is developmentally less mature than human, and depending on the criteria used, rat brain from postnatal days 7-13 is estimated to be developmentally equivalent to newborn human brains (1, 22) . This would mean that some of the time points chosen in this study might actually be reflecting prenatal stages in humans. This is an important point, which might help narrow down the time window for susceptibility to early life stressors in humans especially since the appetite regulating neuropeptide system circuitry is fully developed prenatally (18) compared to rodents where it develops predominantly after birth (17) .
It is clear from the study of Spencer et al therefore that the programming of body weight regulation, as opposed to other LPS induced sickness-type behaviors, is particularly dependent on the time window of exposure. This as the authors suggest is Page 6 of 12 -7 -most likely a reflection of the role of leptin, which might not have been actively regulating energy balance at the time of the brief challenge and therefore not influenced long term. The implications of this study for humans is that a very narrow window and most likely prolonged exposure to infection during development is required to influence body weight regulatory mechanisms.
